Notable Call Options Activity in Immunomedics
Shares of Immunomedics (NASDAQ: IMMU) are lower on the session by 0.63%, currently trading at $3.17. The stock has been moving largely lower over the past three months and is currently trading below the 50-day moving average.
Options traders are focusing on calls today. The strike seeing the heaviest volume is the January 2012 $6.00 call, which has traded 1,000 times on open interest of 4,466 contracts.
Calls are outpacing puts today by 1,000 to 1.
Immunomedics, Inc. is a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases.
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.